VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
HLF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
HLFHerbalife Nutrition Ltd.
$11.99$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHLFFinancials

Herbalife Nutrition Ltd. (HLF) Income Statement

23Y historyFree accessUpdated daily

Revenue growth turned positive at 5.4% YoY in Q2 2026, but operating margin compressed to 9.7% and net income swung to a -$26.3M loss, indicating strained profitability.

Income StatementBalance SheetCash FlowRatios

HLF Income Statement

Annual statement

HLF Income Statement

Herbalife Nutrition Ltd. (HLF) annual income statement — 23-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Sales/Revenue5.2B5.04B4.99B5.06B5.2B5.8B5.54B4.88B4.89B4.43B4.49B4.47B4.96B4.83B4.07B3.45B2.73B2.32B2.36B2.15B1.89B1.57B1.31B1.16B
Revenue Growth %5.52%0.89%-1.37%-2.73%-10.31%4.71%13.63%-0.3%10.48%-1.35%0.43%-9.87%2.76%18.49%17.88%26.34%17.62%-1.47%9.94%13.81%20.35%19.63%12.96%-
Cost of Goods Sold1.25B1.23B1.1B1.19B1.17B1.24B1.15B958M919.3M848.6M854.6M856M982.9M963.42M812.58M680.08M558.81M493.13M458.4M438.38M380.34M315.75M269.91M235.78M
COGS % of Revenue-24.39%22.12%23.53%22.55%21.36%20.76%19.64%18.79%19.17%19.04%19.15%19.82%19.97%19.95%19.69%20.44%21.21%19.43%20.43%20.17%20.15%20.61%20.34%
Gross Profit3.95B3.81B3.89B3.87B4.03B4.56B4.39B3.92B3.97B3.58B3.63B3.61B3.98B3.86B3.26B2.77B2.18B1.83B1.9B1.71B1.51B1.25B1.04B923.65M
Gross Margin %75.87%75.61%77.88%76.47%77.45%78.64%79.24%80.36%81.21%80.83%80.96%80.85%80.18%80.03%80.05%80.31%79.56%78.79%80.57%79.57%79.83%79.85%79.39%79.66%
Gross Profit Growth %--2.05%0.45%-3.95%-11.67%3.92%12.05%-1.34%10.99%-1.51%0.58%-9.12%2.95%18.47%17.49%27.54%18.78%-3.65%11.32%13.44%20.32%20.32%12.57%-
Operating Expenses3.48B3.37B3.5B3.52B3.49B3.83B3.75B3.35B3.29B2.96B3.18B3.03B3.46B3.13B2.6B1.07B887.65M1.54B1.57B1.39B1.25B1.03B901.03M816.61M
OpEx % of Revenue-66.85%70.15%69.43%66.97%65.99%67.68%68.71%67.24%66.9%70.75%67.79%69.82%64.8%63.8%31.11%32.46%66.05%66.49%64.98%66.2%65.86%68.8%70.43%
Selling, General & Admin3.52B3.45B3.51B3.53B1.81B2.01B2.08B1.94B1.96B1.76B1.97B1.78B1.99B1.63B1.26B1.07B887.65M1.54B771.85M1.39B1.25B1.03B901.03M816.61M
SG&A % of Revenue-68.42%70.27%69.64%34.79%34.67%37.44%39.78%39.97%39.72%43.82%39.79%40.15%33.76%30.93%31.11%32.46%66.05%32.72%64.98%66.2%65.86%68.8%70.43%
Research & Development000000000000000000000000
R&D % of Revenue------------------------
Other Operating Expenses-1000K-79.3M-5.5M-10.2M1.68B1.82B1.68B1.41B-57.3M400K1.21B-2.3M-13M1.5B1.34B000000000
Operating Income462.3M441.5M385.9M356.4M545.2M734.1M640.6M568.1M683.1M617.1M458.1M583.6M513.5M735.28M661.45M562.27M387.51M296.03M332.25M313.16M256.95M219.07M138.72M107.04M
Operating Margin %8.89%8.76%7.73%7.04%10.48%12.65%11.56%11.65%13.96%13.94%10.21%13.06%10.36%15.24%16.24%16.28%14.17%12.73%14.08%14.59%13.63%13.98%10.59%9.23%
Operating Income Growth %-14.41%8.28%-34.63%-25.73%14.6%12.76%-16.84%10.7%34.71%-21.5%13.65%-30.16%11.16%17.64%45.1%30.9%-10.9%6.1%21.88%17.29%57.92%29.6%-
EBITDA583.1M562.7M507.3M469.7M660.6M841.7M740.9M665.8M783.5M716.9M556.4M681.6M606.7M820.02M735.83M634.12M456.13M358.47M381.46M348.61M287.28M255.9M189.47M169.68M
EBITDA Margin %11.21%11.17%10.16%9.28%12.69%14.51%13.37%13.65%16.02%16.19%12.4%15.25%12.24%16.99%18.07%18.36%16.68%15.42%16.17%16.25%15.24%16.33%14.47%14.63%
EBITDA Growth %-4.38%10.92%8.01%-28.9%-21.52%13.61%11.28%-15.02%9.29%28.85%-18.37%12.35%-26.01%11.44%16.04%39.02%27.25%-6.03%9.43%21.35%12.26%35.06%11.66%-
D&A (Non-Cash Add-back)120.8M121.2M121.4M113.3M115.4M107.6M100.3M97.7M100.4M99.8M98.3M98M93.2M84.74M74.38M71.85M68.62M62.44M49.21M35.45M30.34M36.83M50.75M62.64M
EBIT407.1M489.5M387.7M368.9M564.1M713.9M649.4M581.1M683.1M617.1M428.4M586.9M538M741.27M667.64M569.64M389.76M300.54M332.25M313.16M256.95M219.07M138.72M107.04M
Net Interest Income-184.5M-205.9M-206M-154.4M-133.2M-148.7M-124.2M-132.4M-161.6M-146.3M-93.4M-94.9M-79.2M-18.6M-10.5M-2.49M-7.42M-5.1M-13.22M-10.57M0000
Interest Income9.4M8.5M12.3M11.5M6.1M4.4M8.8M20.6M19.4M14.5M5.9M5.6M12.5M7.99M6.2M7.37M2.25M0000000
Interest Expense193.9M214.4M218.3M165.9M139.3M153.1M133M153M181M160.8M99.3M100.5M91.7M26.55M16.74M9.86M9.66M5.1M13.22M10.57B00123.31T0
Other Income/Expense-249.1M-166.4M-216.5M-153.4M-120.4M-173.3M-124.2M-116.7M-218.9M-145.9M-93.4M-97.2M-92.2M-18.58M-10.54M-2.49M-7.42M-5.1M-13.22M-10.57M-39.54M-43.92M-123.31M-41.47M
Pretax Income213.2M275.1M169.4M203M424.8M560.8M516.4M451.4M464.2M471.2M364.7M486.4M421.3M716.72M650.91M559.78M380.1M290.93M319.03M302.58M217.41M175.15M15.41M65.57M
Pretax Margin %4.1%5.46%3.39%4.01%8.16%9.66%9.32%9.26%9.49%10.64%8.13%10.88%8.5%14.85%15.98%16.2%13.9%12.52%13.52%14.1%11.53%11.18%1.18%5.66%
Income Tax49.8M46.8M-84.9M60.8M103.5M113.6M143.8M140.4M167.6M257.3M104.7M147.3M112.6M189.19M173.72M147.2M89.56M87.58M97.84M111.13M74.27M82.01M29.73M28.72M
Effective Tax Rate %23.36%17.01%-50.12%29.95%24.36%20.26%27.85%31.1%36.11%54.61%28.71%30.28%26.73%26.4%26.69%26.3%23.56%30.1%30.67%36.73%34.16%46.82%192.84%43.8%
Net Income164.2M228.3M254.3M142.2M321.3M447.2M372.6M311M296.6M213.9M260M339.1M308.7M527.52M477.19M412.58M290.53M203.35M221.19M191.45M143.14M93.14M-14.31M36.85M
Net Margin %3.16%4.53%5.09%2.81%6.17%7.71%6.72%6.38%6.06%4.83%5.79%7.59%6.23%10.93%11.72%11.94%10.63%8.75%9.38%8.92%7.59%5.94%-1.09%3.18%
Net Income Growth %-49.48%-10.22%78.83%-55.74%-28.15%20.02%19.81%4.86%38.66%-17.73%-23.33%9.85%-41.48%10.55%15.66%42.01%42.88%-8.07%15.53%33.75%53.68%750.83%-138.84%-
Net Income (Continuing)163.4M228.3M254.3M142.2M321.3M447.2M372.6M311M296.6M213.9M260M339.1M308.7M527.52M477.19M412.58M290.53M203.35M221.19M191.45M143.14M93.14M-14.31M36.85M
Discontinued Operations000000000000000000000000
Minority Interest7.6M5.7M0000000000000000000000
EPS (Diluted)1.572.202.501.423.234.132.772.201.981.291.511.991.702.461.971.661.160.810.840.660.480.32-0.070.17
EPS Growth %-51.1%-12%76.06%-56.04%-21.79%49.1%25.91%11.11%53.49%-14.57%-24.12%17.06%-30.89%24.87%18.67%43.1%43.21%-3.57%27.27%37.5%50%573.37%-139.76%-
EPS (Basic)-2.222.531.443.264.222.832.261.981.351.572.061.792.572.071.771.230.830.870.690.510.34-0.070.17
Diluted Shares Outstanding104.5M103.6M101.6M100.2M99.5M108.3M134.5M141.6M149.5M165.7M172.2M170.6M181.6M214.8M235.8M249.69M252.99M252.39M263.08M290.86M298.04M289.96M211.64M213.78M
Basic Shares Outstanding104.5M102.8M100.6M99M98.5M105.9M131.5M137.4M149.5M158.5M166.1M165.2M172.6M205.2M224.8M235.08M238.01M244.88M255.14M277.99M283.26M275.89M211.64M213.78M
Dividend Payout Ratio------------9.85%23.33%28.31%20.72%18.5%23.96%22.92%21.69%----

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetMixed
Cash FlowStable
Top Statement Risk

Margin compression and EPS volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Stabilizing Top-Line, Yet Growth Remains Tepid

Herbalife's revenue growth has hovered near zero, with the latest quarter showing 5.4% YoY growth, according to recent financial statements, suggesting a plateau after the post-pandemic surge.

The 5.4% YoY growth in Q2 2026 marks a rebound from negative growth in the prior year, but the absolute revenue level has remained around $1.3B for the past two years, indicating a lack of meaningful volume expansion. This stability appears to be driven by price increases rather than unit growth, as the company faces mature markets and competitive pressures. Investors should monitor whether this modest growth can be sustained without further margin erosion.

Gross Margin Resilience Masks Operating Strain

Gross margin remains high at 77.7% in Q2 2026, as reported in the latest income statement, but operating margin has compressed to 9.7%, reflecting rising distributor compensation and SG&A costs.

The 75-78% gross margin range is consistent with the company's pricing power in the nutritional supplement space, but the gap between gross and operating margins has widened, with SG&A consuming over 68% of revenue in Q2 2026. This suggests that the cost of maintaining the distributor network is escalating, potentially due to increased incentives or administrative overhead. The thin operating margin leaves little room for error if input costs rise or sales volumes falter.

Operating Leverage Fails to Materialize

Despite a 5.4% revenue increase in Q2 2026, operating income grew only 3.4% sequentially, as per the income statement, indicating that overhead costs are scaling with revenue, limiting operating leverage.

The company's SG&A expenses have grown roughly in line with revenue, preventing operating income from expanding at a faster rate. In Q2 2026, SG&A was $902.2M, up from $887.4M in Q4 2025, while revenue increased only modestly. This suggests that the business model requires constant investment in the sales force, making it difficult to achieve economies of scale. Investors should watch for any signs of SG&A discipline that could improve operating leverage.

EPS Volatility Raises Quality Concerns

Net income swung to a loss of $26.3M in Q2 2026, with diluted EPS at -$0.25, according to the latest financials, despite positive operating income, highlighting non-operating items and tax effects.

The significant discrepancy between operating income of $128.3M and net loss suggests that interest expense, taxes, or other non-operating charges are heavily impacting the bottom line. The company's high debt load likely contributes to substantial interest costs, which, combined with a potentially elevated effective tax rate, can cause large swings in EPS. This volatility makes it difficult for investors to rely on quarterly earnings as a measure of underlying performance.

SG&A Dominates Cost Structure

SG&A expenses, including distributor compensation, represent the largest cost line, totaling $902.2M in Q2 2026, as per the income statement, consuming over 68% of revenue and pressuring margins.

The company's cost structure is heavily weighted toward variable costs, particularly distributor royalties and incentives, which are essential to maintaining the sales network. While gross margins are high, the sheer magnitude of SG&A leaves little room for profitability. Management's ability to control these costs without undermining distributor motivation is critical, and any increase in compensation rates could further compress operating margins.

Margin Compression and Regulatory Overhang

The Q2 2026 EPS miss of $0.51 versus consensus of $0.70, as reported in recent filings, suggests that cost pressures and mix shifts are eroding profitability faster than revenue growth can offset.

Short-sellers would likely highlight the persistent gap between gross and operating margins, which has widened over the past year, indicating that the distributor network is becoming more expensive to maintain. Additionally, the company's reliance on a multi-level marketing model exposes it to regulatory risks that could force changes to compensation structures, potentially devastating margins. The lack of meaningful revenue growth and the high debt load further amplify these concerns, making the stock vulnerable to negative sentiment.

HLF — Frequently Asked Questions

Quick answers to the most common questions about buying HLF stock.

What was Herbalife Nutrition Ltd.'s (HLF) revenue in 2025?

For fiscal year 2025, Herbalife Nutrition Ltd. (HLF) reported total revenue of $5.04B. This represents a 334.5% increase compared to $1.16B in 2003.

Is Herbalife Nutrition Ltd. (HLF) profitable?

Herbalife Nutrition Ltd. (HLF) is profitable, generating $228.3M in net income for the fiscal year ending 2025 with a net profit margin of 4.5%.

What is Herbalife Nutrition Ltd.'s operating profit margin?

Herbalife Nutrition Ltd. (HLF) reported an operating income of $441.5M, resulting in an operating profit margin of 8.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Herbalife Nutrition Ltd.'s gross profit and gross margin?

Herbalife Nutrition Ltd. (HLF) generated $3.81B in gross profit for the year, representing a gross profit margin of 75.6%. This demonstrates the company's core pricing power and production efficiency.